EUVIMEDEUVIMED entdecken
Fallbericht

Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome

Marina Hamada, Tokimasa Hida iD, Masashi Idogawa iD, Shoichiro Tange, Takafumi Kamiya, Masae Okura, Toshiharu Yamashita, Takashi Tokino, Hisashi Uhara iD

The Journal of Dermatology · 2025

DOI: 10.1111/1346-8138.17434 ↗

Kurz gefasst

Fallbericht in der Zeitschrift The Journal of Dermatology, 2025. Verfasst von Marina Hamada und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan. Hauptthemen laut MEDLINE: Skin Neoplasms, Mosaicism, Basal Cell Carcinoma, Phenotype. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple hereditary infundibulocystic basal cell carcinoma syndrome (MHIBCC), an autosomal dominant disorder caused by variants in SUFU , is characterized by numerous infundibulocystic basal cell carcinomas (IBCCs). In this report, we present a possible case of mosaic MHIBCC. A 57‐year‐old woman underwent the removal of four papules on her face, which were diagnosed as IBCCs. Exome sequencing revealed a SUFU c.1022+1G>A mutation within the skin tumor. The same mutation was detected in her blood but at a lower allele frequency. TA cloning revealed that the allele frequency of the mutation in the blood was 0.07. Additionally, tumor assessment revealed loss of heterozygosity (LOH) in chromosome 10, including the SUFU locus. These results indicate the patient had mosaicism for the SUFU mutation in normal tissues, aligning with the mosaic MHIBCC diagnosis. This, combined with LOH, likely contributed to IBCC development. Mosaic MHIBCC may present with milder symptoms. However, it may still increase the risk of developing brain tumors and more aggressive basal cell carcinoma. The possibility of mosaicism should be investigated in mild MHIBCC cases, where standard genetic tests fail to detect SUFU germline variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsMosaicismBasal Cell CarcinomaPhenotypeHumansFemaleMiddle AgedLoss of HeterozygosityMutationExome SequencingRepressor Proteins

Stichwörter der Autor:innen

SUFU proteinbasal cell nevus syndromeinfundibulocystic basal cell carcinomamedulloblastomamosaicism

Substanzen

SUFU protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Dermatology, Sapporo Medical University School of Medicine, Sapporo, Japan.
  • Department of Medical Genome Sciences, Cancer Research Institute, Sapporo Medical University School of Medicine, Sapporo, Japan.

ORCID-Profile: Tokimasa Hida, Masashi Idogawa, Hisashi Uhara

Zitieren

APA

Hamada, M., Hida, T., Idogawa, M., Tange, S., Kamiya, T., Okura, M., Yamashita, T., Tokino, T., & Uhara, H. (2025). Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.17434

Vancouver

Hamada M, Hida T, Idogawa M, Tange S, Kamiya T, Okura M, et al. Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome. The Journal of Dermatology. 2025. doi:10.1111/1346-8138.17434

BibTeX
@article{Hamada2025,
  author = {Hamada, Marina and Hida, Tokimasa and Idogawa, Masashi and Tange, Shoichiro and Kamiya, Takafumi and Okura, Masae and Yamashita, Toshiharu and Tokino, Takashi and Uhara, Hisashi},
  title = {Mosaic SUFU mutation associated with a mild phenotype of multiple hereditary infundibulocystic basal cell carcinoma syndrome},
  journal = {The Journal of Dermatology},
  year = {2025},
  doi = {10.1111/1346-8138.17434}
}
Kostenlos starten →